SEC Form 13F
| Report period | 2025-06-30 |
|---|---|
| Publicly available | 2025-08-15 |
| Reported value | $1,065,228,750 |
| Positions | 25 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SPDR S&P 500 ETF TR | SPY | TR UNIT | $308,925,000 | 500,000 |
| ZIMMER BIOMET HOLDINGS INC | ZBH | COM | $91,210,000 | 1,000,000 |
| BAXTER INTL INC | BAX | COM | $86,298,000 | 2,850,000 |
| HUMANA INC | HUM | COM | $73,344,000 | 300,000 |
| CVS HEALTH CORP | CVS | COM | $72,429,000 | 1,050,000 |
| GLOBUS MED INC | GMED | CL A | $47,216,000 | 800,000 |
| ICON PLC | ICLR | SHS | $43,635,000 | 300,000 |
| ASCENDIS PHARMA A/S | ASND | SPONSORED ADR | $43,150,000 | 250,000 |
| MERCK & CO INC | MRK | COM | $39,580,000 | 500,000 |
| GSK PLC | GSK | SPONSORED ADR | $38,400,000 | 1,000,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.